151 related articles for article (PubMed ID: 35931413)
61. First report of hepatobiliary
Namkoong H; Asakura T; Ishii M; Yoda S; Masaki K; Sakagami T; Iwasaki E; Yamagishi Y; Kanai T; Betsuyaku T; Hasegawa N
New Microbes New Infect; 2019 Jan; 27():4-6. PubMed ID: 30505452
[TBL] [Abstract][Full Text] [Related]
62. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.
Höflich C; Sabat R; Rosseau S; Temmesfeld B; Slevogt H; Döcke WD; Grütz G; Meisel C; Halle E; Göbel UB; Volk HD; Suttorp N
Blood; 2004 Jan; 103(2):673-5. PubMed ID: 12947000
[TBL] [Abstract][Full Text] [Related]
63. Disseminated cutaneous Mycobacterium kansasii infection presenting with Rosai-Dorfman disease-like histological features in a patient carrying anti-interferon-γ autoantibodies.
King YA; Hu CH; Lee YJ; Lin CF; Liu D; Wang KH
J Dermatol; 2017 Dec; 44(12):1396-1400. PubMed ID: 28836691
[TBL] [Abstract][Full Text] [Related]
64. [Recurrent atypical mycobacterial infections in the adult: think of autoantibodies against interferon-gamma !].
Picque JB; Blot M; Binois R; Jeudy G; Simonet AL; Cagnon J; Mahy S; Duong M; Buisson M; Chavanet P; Piroth L
Rev Med Interne; 2012 Feb; 33(2):103-6. PubMed ID: 22236500
[TBL] [Abstract][Full Text] [Related]
65. Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.
Hanitsch LG; Löbel M; Müller-Redetzky H; Schürmann M; Suttorp N; Unterwalder N; Mönnich U; Meisel C; Wittke K; Volk HD; Scheibenbogen C; Kölsch U
J Clin Immunol; 2015 May; 35(4):361-5. PubMed ID: 25875701
[TBL] [Abstract][Full Text] [Related]
66. Disseminated
Su SS; Zhang SN; Ye JR; Xu LN; Lin PC; Xu HY; Wu Q; Li YP
Infect Drug Resist; 2019; 12():3189-3195. PubMed ID: 31632104
[TBL] [Abstract][Full Text] [Related]
67. Disseminated Mycobacterium avium Infection Complicated with Chylous Ascites in a Patient with Neutralizing Autoantibodies to Interferon-γ.
Yamaba Y; Takakuwa O; Wang Z; Saito M; Kawae D; Yoshihara M; Kunii E; Ito Y; Akita K
Intern Med; 2020 Dec; 59(24):3195-3200. PubMed ID: 32788530
[TBL] [Abstract][Full Text] [Related]
68. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
[TBL] [Abstract][Full Text] [Related]
69. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.
Patel SY; Ding L; Brown MR; Lantz L; Gay T; Cohen S; Martyak LA; Kubak B; Holland SM
J Immunol; 2005 Oct; 175(7):4769-76. PubMed ID: 16177125
[TBL] [Abstract][Full Text] [Related]
70. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
[TBL] [Abstract][Full Text] [Related]
71. Disseminated Mycobacterium avium complex infection in a patient carrying autoantibody to interferon-γ.
Ishii T; Tamura A; Matsui H; Nagai H; Akagawa S; Hebisawa A; Ohta K
J Infect Chemother; 2013 Dec; 19(6):1152-7. PubMed ID: 23456204
[TBL] [Abstract][Full Text] [Related]
72. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
[TBL] [Abstract][Full Text] [Related]
73. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
[TBL] [Abstract][Full Text] [Related]
74. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
75. Case Report: Disseminated
Kashihara E; Fujita K; Uchida N; Yamamoto Y; Mio T; Koyama H
Am J Trop Med Hyg; 2019 Nov; 101(5):1066-1069. PubMed ID: 31549614
[TBL] [Abstract][Full Text] [Related]
76. Disseminated Talaromyces marneffei and Mycobacterium abscessus in a Patient With Anti-Interferon-γ Autoantibodies.
Pruetpongpun N; Khawcharoenporn T; Damronglerd P; Suthiwartnarueput W; Apisarnthanarak A; Rujanavej S; Suwantarat N
Open Forum Infect Dis; 2016 Apr; 3(2):ofw093. PubMed ID: 27419165
[TBL] [Abstract][Full Text] [Related]
77. Bacillus cereus isolated from a positive bone tissue culture in a patient with osteolysis and high-titer anti-interferon-γ autoantibodies: A case report.
Qiu Y; Zhang J; Li B; Shu H
Medicine (Baltimore); 2019 Oct; 98(43):e17609. PubMed ID: 31651871
[TBL] [Abstract][Full Text] [Related]
78. Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies.
Ochoa S; Ding L; Kreuzburg S; Treat J; Holland SM; Zerbe CS
Clin Infect Dis; 2021 Jun; 72(12):2206-2208. PubMed ID: 32745179
[TBL] [Abstract][Full Text] [Related]
79. R-CHOP Chemotherapy for Disseminated
Uno S; Uehara E; Kimura T; Sakagami T; Namkoong H; Uchida S; Uwamino Y; Hasegawa N
Open Forum Infect Dis; 2021 Jun; 8(6):ofab181. PubMed ID: 34095337
[TBL] [Abstract][Full Text] [Related]
80. Talaromyces marneffei and Mycobacterium tuberculosis co-infection in a patient with high titer anti-interferon-γ autoantibodies: a case report.
Qiu Y; Pan M; Yang Z; Zeng W; Zhang H; Li Z; Zhang J
BMC Infect Dis; 2022 Jan; 22(1):98. PubMed ID: 35090402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
